Your browser doesn't support javascript.
loading
Generation of a photocontrollable recombinant bovine parainfluenza virus type 3.
Okura, Takashi; Tahara, Maino; Otsuki, Noriyuki; Sato, Moritoshi; Takeuchi, Kaoru; Takeda, Makoto.
Afiliación
  • Okura T; Department of Virology 3, National Institute of Infectious Diseases, Tokyo, Japan.
  • Tahara M; Department of Virology 3, National Institute of Infectious Diseases, Tokyo, Japan.
  • Otsuki N; Department of Virology 3, National Institute of Infectious Diseases, Tokyo, Japan.
  • Sato M; Graduate School of Arts and Sciences, The University of Tokyo, Tokyo, Japan.
  • Takeuchi K; Kanagawa Institute of Industrial Science and Technology, Kanagawa, Japan.
  • Takeda M; Laboratory of Environmental Microbiology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
Microbiol Immunol ; 67(4): 204-209, 2023 Apr.
Article en En | MEDLINE | ID: mdl-36609846
Bovine parainfluenza virus type 3 (BPIV3) is a promising vaccine vector against various respiratory virus infections, including the human PIV3, respiratory syncytial virus, and severe acute respiratory syndrome-coronavirus 2 infections. In this study, we combined the Magnet system and reverse genetic approach to generate photocontrollable BPIV3. An optically controllable Magnet gene was inserted into the H2 region of the BPIV3 large protein gene, which encodes an RNA-dependent RNA polymerase. The generated photocontrollable BPIV3 grew in specific regions of the cell sheet only when illuminated with blue light, suggesting that spatiotemporal control can aid in safe clinical applications of BPIV3.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Virus Sincitial Respiratorio Humano / COVID-19 Límite: Animals / Humans Idioma: En Revista: Microbiol Immunol Año: 2023 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Australia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Virus Sincitial Respiratorio Humano / COVID-19 Límite: Animals / Humans Idioma: En Revista: Microbiol Immunol Año: 2023 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Australia